78 related articles for article (PubMed ID: 19142800)
1. Relations of TGF-beta1 with HIF-1 alpha, GLUT-1 and longer survival of colorectal cancer patients.
Sulkowska M; Wincewicz A; Sulkowski S; Koda M; Kanczuga-Koda L
Pathology; 2009; 41(3):254-60. PubMed ID: 19142800
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta1 and regulators of apoptosis.
Sulkowski S; Wincewicz A; Sulkowska M; Koda M
Ann N Y Acad Sci; 2009 Aug; 1171():116-23. PubMed ID: 19723045
[TBL] [Abstract][Full Text] [Related]
3. Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha.
Lidgren A; Bergh A; Grankvist K; Rasmuson T; Ljungberg B
BJU Int; 2008 Feb; 101(4):480-4. PubMed ID: 17922867
[TBL] [Abstract][Full Text] [Related]
4. [Correlations of expressions of Glut1 and HIF-1alpha to cellular proliferation of colorectal adenocarcinoma].
Zhou YL; Deng CS
Ai Zheng; 2005 Jun; 24(6):685-9. PubMed ID: 15946479
[TBL] [Abstract][Full Text] [Related]
5. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
Zhou JT; Cai ZM; Li NC; Na YQ
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593
[TBL] [Abstract][Full Text] [Related]
6. Expression of TGF-beta1, TbetaRII and Smad4 in colorectal carcinoma.
Xu WQ; Jiang XC; Zheng L; Yu YY; Tang JM
Exp Mol Pathol; 2007 Jun; 82(3):284-91. PubMed ID: 17289018
[TBL] [Abstract][Full Text] [Related]
7. Expression of transforming growth factor-beta1 and hypoxia-inducible factor-1alpha in an experimental model of kidney transplantation.
Lario S; Mendes D; Bescós M; Iñigo P; Campos B; Alvarez R; Alcaraz A; Rivera-Fillat F; Campistol JM
Transplantation; 2003 May; 75(10):1647-54. PubMed ID: 12777850
[TBL] [Abstract][Full Text] [Related]
8. Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas.
Ozbudak IH; Karaveli S; Simsek T; Erdogan G; Pestereli E
Gynecol Oncol; 2008 Mar; 108(3):603-8. PubMed ID: 18191183
[TBL] [Abstract][Full Text] [Related]
9. Expression of transforming growth factor-beta1 and hypoxia-inducible factor-1alpha in renal transplantation.
Lee S; Kim DJ; Park MG; Park SK; Kim JS; Hyun SJ; Oh JE; Nam ES; Joo SH
Transplant Proc; 2008 Sep; 40(7):2147-8. PubMed ID: 18790176
[TBL] [Abstract][Full Text] [Related]
10. Hypoxic status in ovarian serous and mucinous tumors: relationship between histological characteristics and HIF-1alpha/GLUT-1 expression.
Iida T; Yasuda M; Miyazawa M; Fujita M; Osamura RY; Hirasawa T; Muramatsu T; Murakami M; Saito K; Mikami M
Arch Gynecol Obstet; 2008 Jun; 277(6):539-46. PubMed ID: 18026974
[TBL] [Abstract][Full Text] [Related]
11. Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis.
Sun HC; Qiu ZJ; Liu J; Sun J; Jiang T; Huang KJ; Yao M; Huang C
Int J Oncol; 2007 Jun; 30(6):1359-67. PubMed ID: 17487356
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological significance and linkage of the distribution of HIF-1alpha and GLUT-1 in human primary colorectal cancer.
Wincewicz A; Sulkowska M; Koda M; Sulkowski S
Pathol Oncol Res; 2007; 13(1):15-20. PubMed ID: 17387384
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
14. Comparison of beta-catenin with TGF-beta1, HIF-1alpha and patients' disease-free survival in human colorectal cancer.
Wincewicz A; Koda M; Sulkowski S; Kanczuga-Koda L; Sulkowska M
Pathol Oncol Res; 2010 Sep; 16(3):311-8. PubMed ID: 19898961
[TBL] [Abstract][Full Text] [Related]
15. Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma.
Jiang CQ; Fan LF; Liu ZS; Qian Q; Xia D; Diao LM; He YM; Ai ZL
Chin Med J (Engl); 2004 Oct; 117(10):1541-6. PubMed ID: 15498380
[TBL] [Abstract][Full Text] [Related]
16. [Relations of transforming growth factor-beta1 expression to differentiation and prognosis of advanced gastric cancer].
Guo RF; Zang SZ; Zhang L; Li WM; Hu FL; Lü YY
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3249-54. PubMed ID: 17313802
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression.
Simiantonaki N; Taxeidis M; Jayasinghe C; Kurzik-Dumke U; Kirkpatrick CJ
BMC Cancer; 2008 Nov; 8():320. PubMed ID: 18983642
[TBL] [Abstract][Full Text] [Related]
18. [Relationship of hypoxia-inducible factor 1 alpha (HIF-1alpha) gene expression with vascular endothelial growth factor (VEGF) and microvessel density (MVD) in human colorectal adenoma and adenocarcinoma].
Jiang CQ; Liu ZS; Qian Q; He YM; Yuan YF; Ai ZL
Ai Zheng; 2003 Nov; 22(11):1170-4. PubMed ID: 14613646
[TBL] [Abstract][Full Text] [Related]
19. Soluble transforming growth factor beta type II receptor attenuates TGF-beta1 activity in human colorectal cancer LoVo cells.
Zhou R; Xiong B; Song H; Liu S; Wang X
Oncol Rep; 2008 Dec; 20(6):1449-56. PubMed ID: 19020727
[TBL] [Abstract][Full Text] [Related]
20. The significance of serum transforming growth factor beta 1 in detecting of gastric and colon cancers.
Coban S; Yüksel O; Koçkar MC; Köklü S; Basar O; Tutkak H; Ormeci N
Hepatogastroenterology; 2007; 54(77):1472-6. PubMed ID: 17708279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
